Bone marrow–derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model

Current evidence supports the use of bone marrow–derived mesenchymal stem cells (MSCs) for a diverse range of clinical applications, and many studies have shown that MSCs have renal‐protective effects, but the mechanism is not well understood. Therefore, in this study, we aim to further identify whe...

Ausführliche Beschreibung